Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery
Perioperative Individually Tailored Psychological Intervention in Breast Cancer Patients Improves Psychological Indices and Molecular Biomarkers of Metastasis in Excised Tumors
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Petah Tikva, Israel, 4941492
- Rabin Medical Center - Beilinson Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women with stage I-III breast cancer
- Scheduled for curative surgery
- Age 20-80
Exclusion Criteria:
- Metastatic disease
- Neoadjuvant therapy
- Other malignancy
- Severe psychiatric conditions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Psychological Intervention
Individually tailored perioperative psychological intervention including six sessions and bi-weekly phone calls targeting emotional, cognitive, physiological, and behavioral stress responses.
|
A 6-week individually tailored psychological intervention delivered perioperatively, including six sessions with a trained medical psychologist and bi-weekly phone calls.
The intervention targets emotional, cognitive, physiological, and behavioral stress responses, and includes psychoeducation, stress-reduction techniques, coping strategies, and enhancement of social support, based on individual patient needs assessed before surgery.
|
|
Active Comparator: Standard Care
Standard nursing staff attention without structured psychological intervention.
|
Standard nursing staff attention (treatment-as-usual) without structured psychological intervention.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tumor gene expression signatures
Time Frame: At surgery (tumor resection)
|
Transcriptional activity of pro-metastatic, inflammatory, and adrenergic signaling pathways in excised tumors assessed via RNA sequencing.
|
At surgery (tumor resection)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological distress (BSI-18)
Time Frame: Baseline (2-3 weeks before surgery), 3-4 weeks after surgery, and 3 months after surgery
|
Psychological distress assessed using the Brief Symptom Inventory-18 (BSI-18), including Global Severity Index (GSI) and subscales for depression, anxiety, and somatization.
|
Baseline (2-3 weeks before surgery), 3-4 weeks after surgery, and 3 months after surgery
|
|
Self-reported stress level
Time Frame: Baseline, 1 day before surgery, 1 day after surgery, 3-4 weeks after surgery, and 3 months after surgery
|
Self-reported stress level assessed using a 1-100 scale reflecting perceived stress during the previous 24 hours.
|
Baseline, 1 day before surgery, 1 day after surgery, 3-4 weeks after surgery, and 3 months after surgery
|
|
Hope (Hope-18)
Time Frame: Baseline and 3-4 weeks after surgery
|
Hope assessed using the Hope-18 questionnaire, including intrapersonal, interpersonal, and transpersonal domains.
|
Baseline and 3-4 weeks after surgery
|
|
Perceived social support (MSPSS)
Time Frame: Baseline and 3-4 weeks after surgery
|
Perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), including family, friends, and significant others subscales.
|
Baseline and 3-4 weeks after surgery
|
|
Fatigue (SF-36 subscale)
Time Frame: Baseline and 3-4 weeks after surgery
|
Fatigue assessed using the fatigue subscale of the Short Form Health Survey (SF-36).
|
Baseline and 3-4 weeks after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RMC-17-0127
- MOH_2017-08-10_000705 (Registry Identifier: Israeli Ministry of Health)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.